Causes and Factors Associated with Frequent Hospitalization in Chinese Patients with Systemic Lupus Erythematosus: An Ambispective Cohort Study

Background Hospitalizations in patients with systemic lupus erythematosus (SLE) have been reported from different regions in the world. This study aimed to evaluate the annual hospitalization rate, causes of hospitalization, and potential factors associated with frequency of hospitalization in Chinese patients. Material/Methods We performed an ambispective cohort study for hospitalized patients with SLE in a Chinese single center. Data on demographics, organ involvements, laboratory abnormities, clinical treatments, causes of hospitalization, and survival outcomes were recorded at the time of SLE diagnosis and during a follow-up period. Poisson regression models were created to identify the potential factors associated with frequency of hospitalization. Results Of 526 patients with SLE, 242 patients (46%) had 1 or more admissions amounting to a total of 449 times during a median follow-up period of 4.73 years. The annual hospitalization rate was 18% and death occurred in 2.5% of total admissions. SLE flare, infection and pregnancy-related morbidity were the most common causes of hospitalization. Besides, the multivariate Poisson regression analysis revealed that decreased albumin, decreased renal function, and high disease damage were the risk factors for more frequency of hospitalization, whereas positive anti-SSA antibody and use of hydroxychloroquine were protective factors. Conclusions Nearly half of patients (46%) with SLE experience 1 or more hospitalizations, mainly due to SLE flare, infection, and pregnancy-related morbidity. Lupus patients with decreased albumin, decreased renal function, and high disease damage are more susceptible to have frequent hospitalization.

[1]  S. Kay,et al.  Hospitalizations among Danish SLE patients: a prospective study on incidence, causes of admission and risk factors in a population-based cohort , 2018, Lupus.

[2]  D. Gladman,et al.  Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center , 2017, The Journal of Rheumatology.

[3]  C. Ritchlin,et al.  Hospitalization of patients with systemic lupus erythematosus is a major cause of direct and indirect healthcare costs , 2017, Lupus.

[4]  T. J. Kim,et al.  The rate of and risk factors for frequent hospitalization in systemic lupus erythematosus: results from the Korean lupus network registry , 2016, Lupus.

[5]  P. Izmirly,et al.  Mortality in Systemic Lupus Erythematosus: an Updated Review , 2016, Current Rheumatology Reports.

[6]  Zhanzheng Zhao,et al.  Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center , 2014, Clinical Rheumatology.

[7]  H. Masmoudi,et al.  Causes and outcome of hospitalisations in Tunisian patients with systemic lupus erythematosus , 2014, Lupus Science & Medicine.

[8]  Xiangpei Li,et al.  Chinese SLE Treatment and Research Group Registry: III. Association of Autoantibodies with Clinical Manifestations in Chinese Patients with Systemic Lupus Erythematosus , 2014, Journal of immunology research.

[9]  Christie M. Bartels,et al.  Mortality and Cardiovascular Burden of Systemic Lupus Erythematosus in a US Population-based Cohort , 2014, The Journal of Rheumatology.

[10]  D. Gladman,et al.  The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus , 2013, The Journal of Rheumatology.

[11]  J. Pope,et al.  All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. , 2013, Rheumatology.

[12]  Gerald McGwin,et al.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[13]  T. Goss,et al.  A structured literature review of the direct costs of adult systemic lupus erythematosus in the US , 2011, Arthritis care & research.

[14]  Lingyun Sun,et al.  Prognostic Indicators of Hospitalized Patients with Systemic Lupus Erythematosus: A Large Retrospective Multicenter Study in China , 2011, The Journal of Rheumatology.

[15]  D. Gladman,et al.  Serum Albumin as a Marker for Disease Activity in Patients with Systemic Lupus Erythematosus , 2010, The Journal of Rheumatology.

[16]  M. Khamashta,et al.  Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review , 2008, Annals of the rheumatic diseases.

[17]  E. Myers,et al.  A national study of the complications of lupus in pregnancy. , 2008, American journal of obstetrics and gynecology.

[18]  G. Chan,et al.  Systemic lupus erythematosus in a tertiary, east Malaysian hospital: admission, readmission and death , 2008 .

[19]  P. Emery,et al.  The validity of the inclusion of "lupus headache" in the Systemic Lupus Erythematosus Disease Activity Index. , 2007, Arthritis and rheumatism.

[20]  M. Ward,et al.  Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. , 2007, Arthritis and rheumatism.

[21]  J. Reveille,et al.  Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) , 2007, Annals of the rheumatic diseases.

[22]  L. Vilá,et al.  Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus , 2006, Lupus.

[23]  Song-min Huang,et al.  Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[24]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[25]  C. Laskin,et al.  Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. , 2005, The Journal of rheumatology.

[26]  D A Isenberg,et al.  Development and initial validation of an updated version of the British Isles Lupus Assessment Group ’ s disease activity index for patients with systemic lupus erythematosus , 2005 .

[27]  I. Bruce,et al.  Development and initial validation of an updated version of the British Isles Lupus Assessment Group ’ s disease activity index for patients with systemic lupus erythematosus , 2005 .

[28]  M. Ward,et al.  Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus. , 2003, Arthritis and rheumatism.

[29]  N. Arden,et al.  Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome , 2003, Lupus.

[30]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[31]  D. Gladman,et al.  Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus , 2001, Lupus.

[32]  N. Bianco,et al.  Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable nuclear antibodies protective? , 2000, Lupus.

[33]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[34]  D. Symmons,et al.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[35]  M. Petri,et al.  Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. , 1992, The Journal of rheumatology.

[36]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.